Helex
2021
2021
Founded in 2021, Helex operates in Healthtech offering first-in-class genetic medicines for renal indications. The company focuses on non-viral targeted delivery and genome editing, utilising its prop...
Funding stage:
Seed
Last funding:
29/10/2025
Total funding:
$3.50 Mn+
Investors